TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
1 other identifier
observational
12
1 country
1
Brief Summary
To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 28, 2014
CompletedFirst Posted
Study publicly available on registry
July 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedJune 8, 2022
June 1, 2022
6 months
July 28, 2014
June 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retinal Thickness
Day 1
Eligibility Criteria
Subjects that have no known ocular pathologies
You may qualify if:
- No known ocular pathologies
You may not qualify if:
- Any known ocular pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Topcon Medical Systems, Inc.
Oakland, New Jersey, 07436, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sunni Patel, PhD
Topcon Corporation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2014
First Posted
July 30, 2014
Study Start
January 1, 2014
Primary Completion
July 1, 2014
Study Completion
August 1, 2014
Last Updated
June 8, 2022
Record last verified: 2022-06